WallStreetZenWallStreetZen

AnalystsDaniil Gataulin
Daniil Gataulin's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 8%
#343 out of 4548 analysts
Average Return
+30.58%
Win Rate
38%10 out of 26
Risk vs Reward
Poor
Good

Daniil Gataulin's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Eyepoint Pharmaceuticals IncEYPT
+758.90%$3.26$28.00
2023-03-02 -
2024-03-01
Strong Buy
Eyepoint Pharmaceuticals IncEYPT
+227.38%$6.50$21.28
2023-05-18 -
2024-04-15
Strong Buy
Ocugen IncOCGN
+121.45%$0.72$1.59
2023-05-07 -
2024-04-15
Strong Buy
Ocugen IncOCGN
+113.75%$0.80$1.71
2023-04-13 -
2024-04-12
Strong Buy
Eyepoint Pharmaceuticals IncEYPT
+69.83%$12.53$21.28
2023-08-02 -
2024-04-15
Strong Buy

Daniil Gataulin Analyst Color

Get additional color on Daniil Gataulin's coverage of popular stocks

Daniil Gataulin's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Adverum Biotechnologies IncADVM
4Strong Buy$40.00+246.92%Reiterates
a month ago
Purple Biotech LtdPPBT
1Strong Buy$11.00+1,786.79%Maintains
a month ago
Regenxbio IncRGNX
6Strong Buy$52.00+188.57%Maintains
a month ago
Outlook Therapeutics IncOTLK
4Strong Buy$60.00+596.06%Upgrades
2 months ago
Oculis Holding AgOCS
1Strong Buy$30.00+149.38%Initiates Coverage On
4 months ago
Eyepoint Pharmaceuticals IncEYPT
4Strong Buy$22.00+3.38%Reiterates
8 months ago
Ocugen IncOCGN
3Strong Buy$4.00+151.57%Maintains
a year ago
Korro Bio IncKRRO
1Strong Buy$7.00N/AInitiates Coverage On
a year ago
Oyster Point Pharma IncOYST
2Hold$13.00N/ADowngrades
a year ago
Applied Genetic Technologies CorpAGTC
2Strong Buy$3.00N/AMaintains
2 years ago
Kodiak Sciences IncKOD
1Strong Buy$18.00N/AMaintains
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.